1,4-Dioxane and beta-hydroxyethoxyacetic acid excretion in urine of humans exposed to dioxane vapors.
作者信息
Young J D, Braun W H, Gehring P J, Horvath B S, Daniel R L
出版信息
Toxicol Appl Pharmacol. 1976 Dec;38(3):643-6. doi: 10.1016/0041-008x(76)90195-2.
PMID:1014018
Abstract
摘要
相似文献
1
1,4-Dioxane and beta-hydroxyethoxyacetic acid excretion in urine of humans exposed to dioxane vapors.暴露于二恶烷蒸气的人体尿液中1,4 - 二恶烷和β - 羟基乙氧基乙酸的排泄情况。
Toxicol Appl Pharmacol. 1976 Dec;38(3):643-6. doi: 10.1016/0041-008x(76)90195-2.
2
Metabolism in vivo of dioxane: identification of p-dioxane-2-one as the major urinary metabolite.二氧六环的体内代谢：对二氧六环 -2- 酮作为主要尿液代谢物的鉴定。
Biochem Pharmacol. 1977 Aug 15;26(16):1535-8. doi: 10.1016/0006-2952(77)90430-0.
3
Rapid method for the simultaneous determination of 1,4-dioxan and its major metabolite, beta-hydroxyethoxyacetic acid, concentrations in plasma and urine.
J Chromatogr. 1977 Mar 21;133(2):263-6. doi: 10.1016/s0021-9673(00)83482-2.
4
Structural identification of p-dioxane-2-one as the major urinary metabolite of p-dioxane.对二氧六环-2-酮作为对二氧六环主要尿液代谢物的结构鉴定。
Naunyn Schmiedebergs Arch Pharmacol. 1977 Oct;299(3):283-7. doi: 10.1007/BF00500322.
5
The dose-dependent fate of 1,4-dioxane in rats.
J Environ Pathol Toxicol. 1978 Nov-Dec;2(2):263-82.
6
Identification of beta-hydroxyethoxyacetic acid as the major urinary metabolite of 1,4-dioxane in the rat.鉴定β-羟基乙氧基乙酸为大鼠体内1,4-二氧六环的主要尿液代谢产物。
Toxicol Appl Pharmacol. 1977 Jan;39(1):33-8. doi: 10.1016/0041-008x(77)90174-0.
7
Effect of mixed-function oxidase modifiers on metabolism and toxicity of the oncogen dioxane.混合功能氧化酶修饰剂对致癌物质二恶烷代谢及毒性的影响。
Cancer Res. 1978 Jun;38(6):1621-5.
8
Dose-dependent fate of 1,4-dioxane in rats.
J Toxicol Environ Health. 1978 Sep-Nov;4(5-6):709-26. doi: 10.1080/15287397809529693.
9
Reliable quantitation of β-hydroxyethoxyacetic acid in human urine by an isotope-dilution GC-MS procedure.采用同位素稀释 GC-MS 程序可靠定量人尿液中的β-羟乙氧基乙酸。
J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Sep 15;935:80-4. doi: 10.1016/j.jchromb.2013.07.017. Epub 2013 Jul 25.
10
Development of a physiologically based pharmacokinetic model for risk assessment with 1,4-dioxane.用于1,4-二氧六环风险评估的基于生理的药代动力学模型的开发。
Toxicol Appl Pharmacol. 1990 Aug;105(1):37-54. doi: 10.1016/0041-008x(90)90357-z.
引用本文的文献
1
Assessment of Non-Occupational 1,4-Dioxane Exposure Pathways from Drinking Water and Product Use.评估饮用水和产品使用中非职业性 1,4-二恶烷暴露途径。
Environ Sci Technol. 2022 Apr 19;56(8):5266-5275. doi: 10.1021/acs.est.1c06996. Epub 2022 Apr 5.
2
Glyoxylate metabolism is a key feature of the metabolic degradation of 1,4-dioxane by Pseudonocardia dioxanivorans strain CB1190.乙醛酸代谢是假诺卡氏菌（Pseudonocardia dioxanivorans） strain CB1190 代谢降解 1,4-二恶烷的一个关键特征。
Appl Environ Microbiol. 2012 May;78(9):3298-308. doi: 10.1128/AEM.00067-12. Epub 2012 Feb 10.
Zotero 插件